Clinical trial Recruiting at 1 site Observational Ages 20 and up

Identifying biomarkers for Alzheimer's disease in the Chinese population

Official title: Identifying Biomarkers in Alzheimer's Disease

Run by Chinese University of Hong Kong · NCT05655650 · Data updated 2026-11-12

This study is trying to find specific signs in blood and brain scans that can help detect Alzheimer's disease earlier in people from the Chinese community.

More Alzheimer Disease trials

Quick facts

Study typeObservational
Ages20 Years and up
SexAll
Enrollment300 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Hong Kong, Hong Hong)
StatusRecruiting
StartedSeptember 1, 2018
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedSeptember 18, 2026
Trial IDNCT05655650 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals of Chinese ethnicity with a clinical diagnosis of probable Alzheimer's disease.

Probably not a fit

Patients with non-Alzheimer's dementia or contraindications for MRI or PET scans may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to identify biomarkers associated with Alzheimer's disease (AD) in a local Chinese population. Participants will undergo a series of cognitive assessments, blood tests, brain MRI scans, brain PET scans, and retinal imaging at baseline and during six yearly follow-ups. The study hypothesizes that blood-based proteomics, retinal imaging, and advanced imaging techniques can enhance the accuracy of early detection and staging of AD. By focusing on early detection, the study seeks to contribute to the understanding of AD progression and potential interventions.

Why it matters

Potential benefit: If successful, this study could lead to improved early detection methods for Alzheimer's disease, allowing for timely interventions.

How similar studies have gone: Other studies have shown promise in identifying biomarkers for Alzheimer's disease, but this specific approach focusing on the Chinese population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Chinese ethnicity
* \[For dementia group, clinical diagnosis of "probable Alzheimer's disease" according to recommendation from the National Institute on Aging-Alzheimer's Association workgroups (NIA-AA)

Exclusion Criteria:

* Clinical diagnosis of non-AD dementia
* contraindication for MRI or PET

Where it's running

  • Chinese University of Hong Kong
    Hong Kong, Hong Hong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.